Skip to main
University-wide Navigation

UK Project Receives $3.2 Million for Nonmedical Prescription Opioid Use Research

The research team will recruit 800 Black American nonmedical prescription opioid users and interview them to develop an understanding of the characteristics associated with their drug use and treatment use.

UK Study Reveals “Wasp Dope” Use in Appalachian Kentucky

Wasp dope is a crystalline substance created by electrifying pyrethroid-containing substances – such as wasp sprays – that may give users a methamphetamine-like “rush.” Recent reports have highlighted the emergence of this new drug as an issue of concern, research into the substance is so far lacking.

New UK Study Shows Multidisciplinary Approach Successful in Curbing Opioid Use

To curb overdose deaths, ease the financial burden on health care, and improve patient outcomes, the researchers worked with patients who need tools for recovery from opioid use disorder, such as mental health therapists, relapse-prevention services, and necessary medications.  

UK Substance Use Experts Featured on Emmy-winning Documentary Series

Two University of Kentucky faculty will be featured in an upcoming episode of “Your Fantastic Mind,” an Emmy-nominated television series featuring compelling stories on brain-related health and wellness.

UK Study Explores New Strategies to Recruit Participants into Research on Drug Use

“It’s difficult for people who use drugs to be open about [their drug use] because of the stigma it carries and the potential of criminal justice involvement,” Young said. “We tried to create a welcoming environment in our field office, and we put ourselves out there.”

College of Pharmacy Receives $11.8 Million to Further Substance Use Disorder Research

The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.

UK Researchers Highlight Issues with Buprenorphine Dispensing in New England Journal of Medicine

The team suggests a number of changes to help rebuild trust and reduce stigma for opioid use disorder in rural communities; they also suggest that wholesalers change algorithms to track buprenorphine separately from other opioids.

UK HEALing Communities Strategy Fast-Tracked Due to COVID-19

The ambitious study is organized into six phases, beginning with the basic preparations and leading into actual implementation and monitoring of various evidence-based strategies to reduce opioid deaths.

New Study Reveals Pharmacy-level Barriers to Treatment for Opioid Use Disorder in Appalachian Kentucky

A new study led by UK researcher April Young and Emory researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD).

UK’s Substance Use Research Day Highlights Work of UK Faculty and Students

"It's a wonderful showcase of the breadth and depth of our research." Substance Use Research Day highlights the impactful work of UK faculty, staff and students.

Filter News